2 domains / 4 areas / 2 specializations
CUIMC
Also known as: Columbia University Irving Medical Center
Data updated
Columbia University Irving Medical Center (CUIMC) is a major academic medical centre in New York City, integrating Columbia University's Vagelos College of Physicians and Surgeons with NewYork-Presbyterian Hospital and conducting research across neuroscience, psychiatry, and translational medicine. CUIMC serves as the primary clinical site for the Ketamine Biomarker Validation trial (NCT07307768), an EEG-based Phase I study examining dose-response relationships across three ketamine infusion levels in adults with treatment-resistant major depressive disorder.
Academic Research
0 papersPublished Papers
0
Trial Involvement
1
Distinct Focus Topics
0
Latest Publication
Unknown
Clinical Care Delivery Snapshot
Health Systems & HospitalsProvider Model
Health System / Hospital Program
Organization Status
Unknown
Psychedelic Services
Unknown
Service Coverage
Global
Service Profile
Care Settings
Payer Models
Non-Psychedelic Service Mix
Unknown
Care Delivery Notes
Backfilled profile for existing L2 clinical care delivery stakeholder.
Quick Facts
- Type
- Other
- HQ
- United States
- Website
- Visit